Jintao He

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective study.

Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective study.

Journal: Journal of advanced research
Published: July 16, 2025

Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer.

Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer.

Journal: Chinese medical journal
Published: January 04, 2025

Local tumour residue after microwave ablation for lung cancer: a case report.

Local tumour residue after microwave ablation for lung cancer: a case report.

Journal: Interactive cardiovascular and thoracic surgery
Published: October 28, 2022

Circ_0024108 promotes the progression of esophageal cancer cells.

Circ_0024108 promotes the progression of esophageal cancer cells.

Journal: General thoracic and cardiovascular surgery
Published: October 25, 2022

Low level of complement factor H increases the risk of cancer-related death in patients with small-cell lung cancer.

Low level of complement factor H increases the risk of cancer-related death in patients with small-cell lung cancer.

Journal: Postgraduate medical journal
Published: September 14, 2021

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou).

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou).

Journal: Translational lung cancer research
Published: June 18, 2021

MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1.

MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1.

Journal: Science progress
Published: April 29, 2021

Corrigendum to "ErbB3 ligand, Heregulin1, is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation" [Neoplasia 21 (2019) 343-352].

Corrigendum to "ErbB3 ligand, Heregulin1, is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation" [Neoplasia 21 (2019) 343-352].

Journal: Neoplasia (New York, N.Y.)
Published: March 31, 2021

RSPH14 regulates the proliferation, cell cycle progression, and apoptosis of non-small cell lung cancer cells.

RSPH14 regulates the proliferation, cell cycle progression, and apoptosis of non-small cell lung cancer cells.

Journal: FEBS open bio
Published: September 27, 2020

Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.

Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.

Journal: Thoracic cancer
Published: October 31, 2019

Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients with lung cancer: a multicentre, prospective, observational cohort study protocol.

Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients with lung cancer: a multicentre, prospective, observational cohort study protocol.

Journal: BMJ open
Published: October 31, 2019

Mutation Profile of Tibetan Lung Cancer Revealed by Whole Exome Sequencing.

Mutation Profile of Tibetan Lung Cancer Revealed by Whole Exome Sequencing.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 02, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026